Financial Daily from THE HINDU group of publications
Friday, Apr 30, 2004
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Announcements


Ranbaxy study

Our Bureau

NEW DELHI: Ranbaxy Pharmaceuticals Inc, a wholly owned subsidiary of Ranbaxy Laboratories Ltd, will make a presentation on its metformin hydrochloride oral solution used for diabetes at the American Association of Clinical Endocrinologists' (AACE) 13th Annual Meeting and Clinical Congress on May 1.

More Stories on : Announcements | Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
SBL lines up homeopathic launches

MPM Group plans to open malls in Jaipur, Bangalore
Skoda to bring in Octavia Rider in May
Prize Petroleum-Aban consortium lands ONGC deal
Ranbaxy study
FACT plans second round of VRS
`FedEx committed to corporate social responsibility'
BIFR directs trifurcation of Ferro Alloys Corpn — Results for fourth quarter postponed
Bombay Dyeing retains rating
Pfizer to appoint valuers for Pharmacia merger
Jindal Steel to complete expansion ahead of schedule
HLL chalks out 10-point plan to rebuild margins
Reliance lays out Rs 35,000-cr capex plans
Nestle India to tap new markets to boost exports
Reliance: Both petrochemicals, oil refining drive growth
Hindustan Lever — Under pressure on several fronts
In-house R&D products fetch BHEL Rs 575 cr

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line